论文部分内容阅读
本课题通过对上海药品不良反应数据库中心血管药物及糖尿病药物不良反应信息进行分析,同时结合临床调研及文献研读,完成了对噻唑烷二酮类及血管紧张素受体拮抗剂类药物不良反应信息的初步分析。在此基础上,与临床机构合作,主动收集心血管药物及糖尿病药物中重点监测品种的相关安全信息,从而针对这两类药物的使用提出风险管理建议,并探索研究不良反应自发呈报与主动监测相结合的品种重点监测工作模式,以便及时发现潜在的风险信号,采取控制措施。
This topic through the Shanghai ADR database analysis of cardiovascular drugs and adverse drug reactions of diabetes mellitus, combined with clinical research and literature review, completed the thiazolidinedione and angiotensin receptor antagonist drugs adverse reaction information The initial analysis. On this basis, in cooperation with clinical agencies, we take the initiative to collect relevant safety information of key monitoring species in cardiovascular drugs and diabetes drugs, put forward risk management suggestions on the use of these two types of drugs, and explore the study of spontaneous reporting and active monitoring of adverse reactions The combination of varieties of key monitoring mode of work in order to detect potential risk signals in time to take control measures.